Three Mid-Tier Companies with Above-Market Growth
Current position, sales performance and recent developments for Treace Medical, Xtant Medical and BONESUPPORT....
Jun 03, 2025,
Three Mid-Tier Companies with Above-Market Growth
See All AI Raises Funds for AI-based Visualization and Navigation
The platform transforms 2D C-arm fluoroscopic X-rays into navigable 3D volumes with 1mm cross-sectional slices, eliminating pre-operative CTs, MRIs, other...
Jun 02, 2025,
First Patients Treated in New Trial of MISHA Knee System
Moximed's MOTION RCT prospective, multicenter study compares the benefits in subjects with medial knee OA who are treated with either...
Jun 02, 2025,
Accelus Secures New Growth Financing
The capital will support Accelus’s continued commercial growth and further development of its differentiated spinal implant technologies....
May 29, 2025,
Xtant Medical Launches OsteoFactor Pro
OsteoFactor Pro is a blend of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic...
May 28, 2025,
Orthopedic Executives Talk First Quarter of 2025
Selected comments from the leaders of top orthopedic companies as they reported first quarter 2025 earnings....
May 28, 2025,
Hyprevention Gains Breakthrough Designation for Y-STRUT Implant
The Y-STRUT is part of the company's STRUTPLASTY technology to reinforce bones weakened by osteoporosis or cancer. ...
May 27, 2025,
Exactech Launches Next-Generation Shoulder Planning App
A major update introduces features to enhance surgical precision and streamline the planning process for shoulder replacement surgeries....
May 27, 2025,
Surgify Medical Raises €7 Million for Bone Cutting Technology
Surgify Halo cuts bone while providing protective capabilities against incidental injuries to soft tissues....
May 27, 2025,
Medtronic Cites Technology as Key Differentiator in Spine
The company grew in the mid-single-digits during its fiscal 2025 on the strength of its differentiated enabling technology....
May 22, 2025,
Loading new posts...
No more posts
